查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386362

轮状病毒疫苗市场报告：2030 年趋势、预测与竞争分析

Rotavirus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

轮状病毒疫苗的趋势与预测

预计到 2030 年，全球轮状病毒疫苗市场预计将达到 179 亿美元，2024 年至 2030 年年复合成长率为 10.1%。该市场的主要驱动因素是轮状病毒感染病例和死亡率的增加、医疗保健专业人员和家长对轮状病毒疫苗益处的认识不断提高。全球轮状病毒疫苗市场的未来性充满希望，医院/诊所、学术和研究市场充满机会。

轮状病毒疫苗市场洞察

根据 Lucintel 的预测，Rotarix 预计将在预测期内实现最高成长。

由于对轮状病毒感染疾病早期检测和治疗的需求不断增加、医疗基础设施投资增加以及该地区人口持续增长，预计亚太地区将在预测期内实现最高增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球轮状病毒疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球轮状病毒疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 全球轮状病毒疫苗市场（按类型）
    • 轮转
    • 旋转
    • 罗塔文-M1
    • Lanzhou lamb
    • 其他的
  • 全球轮状病毒疫苗市场（依最终用途）
    • 医院和诊所
    • 学术与研究
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球轮状病毒疫苗市场区域分布
  • 北美轮状病毒疫苗市场
  • 欧洲轮状病毒疫苗市场
  • 亚太地区轮状病毒疫苗市场
  • 其他区域轮状病毒疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球轮状病毒疫苗市场成长机会
    • 全球轮状病毒疫苗市场成长机会（依最终用途）
    • 全球轮状病毒疫苗市场成长机会（按地区）
  • 全球轮状病毒疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球轮状病毒疫苗市场产能扩张
    • 全球轮状病毒疫苗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • BIOVIRx
  • Serum Institute of India
  • Merck & Co
  • Bharat Biotech
  • Biological E
  • Bio Farma
  • Novartis
  • GlaxoSmithKline
  • Sanofi
  • Lanzhou Institute of Biologicals Products
简介目录

Rotavirus Vaccine Trends and Forecast

The future of the global rotavirus vaccine market looks promising with opportunities in the hospital and clinic, academic, and research markets. The global rotavirus vaccine market is expected to reach an estimated $17.9 billion by 2030 with a CAGR of 10.1% from 2024 to 2030. The major drivers for this market are augmenting cases and mortality of rotavirus infection and rising awareness about the benefits of rotavirus vaccines among healthcare professionals and parents/caregivers.

A more than 150-page report is developed to help in your business decisions.

Rotavirus Vaccine by Segment

The study includes a forecast for the global rotavirus vaccine by type, end use, and region.

Rotavirus Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Rotarix
  • Rotateq
  • Rotavin-M1
  • Lanzhou Lamb
  • Others

Rotavirus Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Academic and Research
  • Others

Rotavirus Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Rotavirus Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rotavirus vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rotavirus vaccine companies profiled in this report include-

  • Biovirx
  • Serum Institute of India
  • Merck & Co
  • Bharat Biotech
  • Biological E
  • Bio Farma
  • Novartis
  • Glaxosmithkline
  • Sanofi
  • Lanzhou Institute of Biologicals Products

Rotavirus Vaccine Market Insights

Lucintel forecasts that rotarix is expected to witness highest growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to growing demand for early detection and treatment of rotavirus infections, rising investment in healthcare infrastructural development, and continuous population growth in the region.

Features of the Global Rotavirus Vaccine Market

Market Size Estimates: Rotavirus vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rotavirus vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Rotavirus vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the rotavirus vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rotavirus vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rotavirus vaccine market size?

Answer: The global rotavirus vaccine market is expected to reach an estimated $17.9 billion by 2030.

Q.2 What is the growth forecast for rotavirus vaccine market?

Answer: The global rotavirus vaccine market is expected to grow with a CAGR of 10.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rotavirus vaccine market?

Answer: The major drivers for this market are augmenting cases and mortality of rotavirus infection and rising awareness about the benefits of rotavirus vaccines among healthcare professionals and parents/caregivers.

Q4. What are the major segments for rotavirus vaccine market?

Answer: The future of the rotavirus vaccine market looks promising with opportunities in the hospital and clinic, academic, and research markets.

Q5. Who are the key rotavirus vaccine market companies?

Answer: Some of the key rotavirus vaccine companies are as follows:

  • Biovirx
  • Serum Institute of India
  • Merck & Co
  • Bharat Biotech
  • Biological E
  • Bio Farma
  • Novartis
  • Glaxosmithkline
  • Sanofi
  • Lanzhou Institute of Biologicals Products

Q6. Which rotavirus vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that rotarix is expected to witness highest growth over the forecast period.

Q7. In rotavirus vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing demand for early detection and treatment of rotavirus infections, rising investment in healthcare infrastructural development, and continuous population growth in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the rotavirus vaccine market by type (rotarix, rotateq, rotavin-m1, lanzhou lamb, and others), end use (hospitals and clinics, academic and research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rotavirus Vaccine Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Rotavirus Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Rotavirus Vaccine Market by Type
    • 3.3.1: Rotarix
    • 3.3.2: RotaTeq
    • 3.3.3: Rotavin-M1
    • 3.3.4: Lanzhou lamb
    • 3.3.5: Others
  • 3.4: Global Rotavirus Vaccine Market by End Use
    • 3.4.1: Hospitals and Clinics
    • 3.4.2: Academic and Research
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Rotavirus Vaccine Market by Region
  • 4.2: North American Rotavirus Vaccine Market
    • 4.2.2: North American Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
  • 4.3: European Rotavirus Vaccine Market
    • 4.3.1: European Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
    • 4.3.2: European Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
  • 4.4: APAC Rotavirus Vaccine Market
    • 4.4.1: APAC Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
    • 4.4.2: APAC Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others
  • 4.5: ROW Rotavirus Vaccine Market
    • 4.5.1: ROW Rotavirus Vaccine Market by Type: Rotarix, RotaTeq, Rotavin-M1, Lanzhou lamb, and Others
    • 4.5.2: ROW Rotavirus Vaccine Market by End Use: Hospitals and Clinics, Academic and Research, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Rotavirus Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Rotavirus Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Rotavirus Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Rotavirus Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Rotavirus Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rotavirus Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BIOVIRx
  • 7.2: Serum Institute of India
  • 7.3: Merck & Co
  • 7.4: Bharat Biotech
  • 7.5: Biological E
  • 7.6: Bio Farma
  • 7.7: Novartis
  • 7.8: GlaxoSmithKline
  • 7.9: Sanofi
  • 7.10: Lanzhou Institute of Biologicals Products